Literature DB >> 26760100

Chimeric Antigen Receptor T Cells in Myeloma.

Alfred L Garfall, Edward A Stadtmauer, Carl H June.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26760100     DOI： 10.1056/NEJMc1512760

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  T cells expressing chimeric antigen receptor promote immune tolerance.

Authors:  Antonio Pierini; Bettina P Iliopoulou; Heshan Peiris; Magdiel Pérez-Cruz; Jeanette Baker; Katie Hsu; Xueying Gu; Ping-Ping Zheng; Tom Erkers; Sai-Wen Tang; William Strober; Maite Alvarez; Aaron Ring; Andrea Velardi; Robert S Negrin; Seung K Kim; Everett H Meyer
Journal:  JCI Insight       Date:  2017-10-19

2.  Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes.

Authors:  Genevieve L Coe; Priscilla S Redd; Amy V Paschall; Chunwan Lu; Lilly Gu; Houjian Cai; Thomas Albers; Iryna O Lebedyeva; Kebin Liu
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

3.  Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma.

Authors:  Alejandra Leivas; Antonio Perez-Martinez; María Jesús Blanchard; Estela Martín-Clavero; Lucía Fernández; Juan José Lahuerta; Joaquín Martinez-Lopez
Journal:  Oncoimmunology       Date:  2016-11-22       Impact factor: 8.110

Review 4.  Allograft for Myeloma: Examining Pieces of the Jigsaw Puzzle.

Authors:  Ehsan Malek; Najla El-Jurdi; Nicolaus Kröger; Marcos de Lima
Journal:  Front Oncol       Date:  2017-12-11       Impact factor: 6.244

Review 5.  Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma.

Authors:  Naoki Hosen
Journal:  Cancers (Basel)       Date:  2019-12-15       Impact factor: 6.639

Review 6.  BCMA-targeted immunotherapy for multiple myeloma.

Authors:  Bo Yu; Tianbo Jiang; Delong Liu
Journal:  J Hematol Oncol       Date:  2020-09-17       Impact factor: 17.388

7.  Targeting the Phosphatidylserine-Immune Checkpoint with a Small-Molecule Maytansinoid Conjugate.

Authors:  Chen-Fu Lo; Tai-Yu Chiu; Yu-Tzu Liu; Pei-Yun Pan; Kuan-Liang Liu; Chia-Yu Hsu; Ming-Yu Fang; Yu-Chen Huang; Teng-Kuang Yeh; Tsu-An Hsu; Chiung-Tong Chen; Li-Rung Huang; Lun Kelvin Tsou
Journal:  J Med Chem       Date:  2022-09-26       Impact factor: 8.039

Review 8.  Recent advances in understanding multiple myeloma.

Authors:  Binod Dhakal; Saulius Girnius; Parameswaran Hari
Journal:  F1000Res       Date:  2016-08-23

9.  Clinical trials of CAR-T cells in China.

Authors:  Bingshan Liu; Yongping Song; Delong Liu
Journal:  J Hematol Oncol       Date:  2017-10-23       Impact factor: 17.388
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.